Stockpolly
Search
GLPG · NASDAQ · Biotechnology

Galapagos (ADR) (GLPG)

Belgian biotech shifting from cell therapy toward partnered immunology and oncology assets.

$27.98
At close+0.47 (+1.71%)
Watchlist

In millions of USD, except per-share figures · converted from EUR at the latest rate

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue139−243729069888776831,046814
Cost of revenue7983190131165131611
Gross profit133−243707169−437170701,04524
168−162108116133292551373561647657
Research & development116−828385108666212111861253630
98−1023618544851224034127
Selling & marketing79−1003−21185−43−330
General & administrative19−2322044404626377380
Other expenses−4722−1112−30−685−8423036−10
Operating income−35−80−38−44−63−73−184−66−286881−74−53
65865496953−5529289056
Interest income0323028272215120000
Interest expense0000001027100
Other non-operating income−70−5−65−114114−216051−5623000
Income before tax30−72275−5722−182−121−257909162
Income tax expense0−5−1−1−10−20−20100
Net income from continuing operations30−67275−5622−179−121−237909162
Discontinued operations00775−271−22010
Other adjustments02500000000000
Net income3018310510−5929−178−123−235908172
EPS, basic$0.45$2.78$1.59$0.16−$0.86$0.34−$2.71−$1.87−$3.60$13.79$0.26$0.04
EPS, diluted$0.45$2.78$1.59$0.16−$0.86$0.34−$2.71−$1.87−$3.60$13.79$0.26$0.04
Weighted average shares, basic666666666667666665666670
Weighted average shares, diluted666666666667666666666670
EBITDA35−752791−177−63−184−117−220651−74−53
Depreciation & amortization000210100010000
EBIT35−752770−177−73−184−117−230651−74−53